Maja Mandić
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Immunology 11
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 3
-
- vaccines and immunoinformatics approaches 5
- Co-authors
- John M. Kirkwood (8 shared papers)Hassane M. Zarour (4 shared papers)Walter J. Storkus (6 shared papers)Anna Lokshin (1 shared paper)Tatiana Raskovalova (1 shared paper)Xiao‐Jun Huang (1 shared paper)Elieser Gorelik (1 shared paper)Yunyun Su (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Journal of Immunotherapy (3 papers)The Journal of Immunology (2 papers)Cancer Research (2 papers)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesSerbiaSlovakia
In The Last Decade
Maja Mandić
19 papers receiving 479 citations
Peers
Comparison fields: 5 of 73
- Physiology 66
- Immunology 246
- Oncology 195
- Molecular Biology 247
- Immunology and Allergy 14
Countries citing papers authored by Maja Mandić
This map shows the geographic impact of Maja Mandić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Mandić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Mandić more than expected).
Fields of papers citing papers by Maja Mandić
This network shows the impact of papers produced by Maja Mandić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Mandić. The network helps show where Maja Mandić may publish in the future.
Co-authors
The 25 scholars most cited alongside Maja Mandić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 101 | |
| 2 | 2007 | 71 | |
| 3 | 2005 | 57 | |
| 4 | 2008 | 40 | |
| 5 | The alternative open reading frame of LAGE-1 gives rise to multiple promiscuous HLA-DR-restricted epitopes recognized by T-helper 1-type tumor-reactive CD4+ T cells. | 2003 | 34 |
| 6 | 2007 | 32 | |
| 7 | 2009 | 30 | |
| 8 | 2008 | 24 | |
| 9 | 2010 | 20 | |
| 10 | 2014 | 18 | |
| 11 | 2014 | 17 | |
| 12 | 2008 | 11 | |
| 13 | 2016 | 11 | |
| 14 | 2017 | 6 | |
| 15 | 2015 | 6 | |
| 16 | 2017 | 3 | |
| 17 | 2019 | 1 | |
| 18 | 2005 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2024 | 0 |
About Maja Mandić
Maja Mandić is a scholar working on Immunology, Molecular Biology, Oncology, Pediatrics, Perinatology and Child Health and Small Animals, having authored 21 papers that have together received 484 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (6 papers), vaccines and immunoinformatics approaches (5 papers), Immune Cell Function and Interaction (3 papers), Parasite Biology and Host Interactions (2 papers), CAR-T cell therapy research (2 papers), Pharmaceutical studies and practices (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Physiology (66 citations), Immunology (246 citations), Oncology (195 citations), Molecular Biology (247 citations) and Immunology and Allergy (14 citations). Maja Mandić has collaborated with scholars based in United States, Serbia and Slovakia. Frequent co-authors include John M. Kirkwood, Hassane M. Zarour, Walter J. Storkus, Anna Lokshin, Tatiana Raskovalova, Xiao‐Jun Huang, Elieser Gorelik, Yunyun Su, Edwin K. Jackson and Amy Wesa. Their work appears in journals such as The Journal of Clinical Pharmacology, Journal of Immunotherapy, The Journal of Immunology, Cancer Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.